FDA Clearance Tracker · K232405
ENDOFIX EXO
Last checked: Nov 20, 2026Latest source record: Apr 25, 2024 (this decision)Source: openFDAMethods & limitations
Decided
Apr 25, 2024
Substantially Equivalent
Time to decision
259 days
Received Aug 10, 2023. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K232405
- Device name
- ENDOFIX EXO
- Applicant
- Aktormed GmbH
- Applicant location
- Neutraubling, DE
- Received
- Aug 10, 2023
- Decided
- Apr 25, 2024
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Endoscope Holder (OCV)
- Device class
- Class II
- Regulation
- 21 CFR 876.1500
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code OCV. The earliest in FDA's data is K810787, decided Mar 31, 1981.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K232405
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Aktormed GmbH
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K261573 · Decided Jul 20, 2026 · 69 days after receipt
Device type: Software Controlled Endoscope And Instrument Holder (QZB) · GI, Urology & Nephrology
K233312 · Decided Aug 8, 2024 · 314 days after receipt
Device type: Software Controlled Endoscope And Instrument Holder (QZB) · GI, Urology & Nephrology
K200473 · Decided Dec 22, 2020 · 300 days after receipt
Device type: System, Surgical, Computer Controlled Instrument (NAY) · GI, Urology & Nephrology
1 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.